Gilead

Results: 784



#Item
1KEI request for investigation into anticompetitive aspects of Gilead Voluntary Licenses for patents on Tenofivir and Emtricitabine 12 February 2007 Federal Trade Commission Washington, DC Attn: Randy Marks

KEI request for investigation into anticompetitive aspects of Gilead Voluntary Licenses for patents on Tenofivir and Emtricitabine 12 February 2007 Federal Trade Commission Washington, DC Attn: Randy Marks

Add to Reading List

Source URL: www.keionline.org

Language: English - Date: 2017-11-20 13:59:46
    2C O R P O R AT E CONTRIBUTIONS HIGHLIGHTS SUMMARY  PA R T N E R S H I P S T H AT D E L I V E R T H E

    C O R P O R AT E CONTRIBUTIONS HIGHLIGHTS SUMMARY PA R T N E R S H I P S T H AT D E L I V E R T H E

    Add to Reading List

    Source URL: gilead.com

    - Date: 2015-08-11 17:35:37
      3Cemetery of the Month: Mt. Gilead Cemetery, Monroe County The Mt. Gilead Cemetery was founded in 1845 in Section 25 of Bloomington directly to the East of the former Mt. Gilead Christian Church at Mt. Gilead Road and SR

      Cemetery of the Month: Mt. Gilead Cemetery, Monroe County The Mt. Gilead Cemetery was founded in 1845 in Section 25 of Bloomington directly to the East of the former Mt. Gilead Christian Church at Mt. Gilead Road and SR

      Add to Reading List

      Source URL: www.monroehistory.org

      - Date: 2016-06-30 14:45:31
        4   Earthquake Early Warning and the Physics of Earthquake Rupture By Gilead Wurman

          Earthquake Early Warning and the Physics of Earthquake Rupture By Gilead Wurman

        Add to Reading List

        Source URL: earthquakes.berkeley.edu

        - Date: 2014-06-17 17:41:56
          5January 22, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Gilead Sciences, Galapagos Close $2 Billion Deal for Anti­Infla

          January 22, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Gilead Sciences, Galapagos Close $2 Billion Deal for Anti­Infla

          Add to Reading List

          Source URL: www.dcat.org

          - Date: 2016-01-25 10:14:20
            6Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

            Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

            Add to Reading List

            Source URL: www.aidshealth.org

            Language: English - Date: 2016-01-26 15:03:13
            7March 4, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

            March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

            Add to Reading List

            Source URL: www.dcat.org

            Language: English - Date: 2016-03-30 10:03:18
            8Microsoft Word - GILEAD BRIEFING

            Microsoft Word - GILEAD BRIEFING

            Add to Reading List

            Source URL: www.ukts.org

            Language: English - Date: 2016-07-02 14:50:25
            9Patient Name:________________________________________ Date of Birth:__________________  Truvada® for Pre-Exposure Prophylaxis (PrEP) Medication Assistance Program Page 1 of 4

            Patient Name:________________________________________ Date of Birth:__________________ Truvada® for Pre-Exposure Prophylaxis (PrEP) Medication Assistance Program Page 1 of 4

            Add to Reading List

            Source URL: start.truvada.com

            Language: English - Date: 2016-01-11 14:57:31
            10--------------------------------CONTRAINDICATIONS-----------------------------­ EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN

            --------------------------------CONTRAINDICATIONS-----------------------------­ EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN

            Add to Reading List

            Source URL: www.accessdata.fda.gov

            Language: English - Date: 2016-06-28 12:26:37